234 related articles for article (PubMed ID: 23542580)
21. Choline ameliorates cardiac hypertrophy by regulating metabolic remodelling and UPRmt through SIRT3-AMPK pathway.
Xu M; Xue RQ; Lu Y; Yong SY; Wu Q; Cui YL; Zuo XT; Yu XJ; Zhao M; Zang WJ
Cardiovasc Res; 2019 Mar; 115(3):530-545. PubMed ID: 30165480
[TBL] [Abstract][Full Text] [Related]
22. The therapeutic effect of rosuvastatin on cardiac remodelling from hypertrophy to fibrosis during the end-stage hypertension in rats.
Zhang WB; Du QJ; Li H; Sun AJ; Qiu ZH; Wu CN; Zhao G; Gong H; Hu K; Zou YZ; Ge JB
J Cell Mol Med; 2012 Sep; 16(9):2227-37. PubMed ID: 22288611
[TBL] [Abstract][Full Text] [Related]
23. Mechanism of the inhibitory effect of atorvastatin on endoglin expression induced by transforming growth factor-beta1 in cultured cardiac fibroblasts.
Shyu KG; Wang BW; Chen WJ; Kuan P; Hung CR
Eur J Heart Fail; 2010 Mar; 12(3):219-26. PubMed ID: 20156938
[TBL] [Abstract][Full Text] [Related]
24. AdipoRon, an adiponectin receptor agonist, attenuates cardiac remodeling induced by pressure overload.
Zhang N; Wei WY; Liao HH; Yang Z; Hu C; Wang SS; Deng W; Tang QZ
J Mol Med (Berl); 2018 Dec; 96(12):1345-1357. PubMed ID: 30341569
[TBL] [Abstract][Full Text] [Related]
25. Effects of Adiponectin on Diastolic Function in Mice Underwent Transverse Aorta Constriction.
Han X; Wang Y; Fu M; Song Y; Wang J; Cui X; Fan Y; Cao J; Luo J; Sun A; Zou Y; Hu K; Zhou J; Ge J
J Cardiovasc Transl Res; 2020 Apr; 13(2):225-237. PubMed ID: 31621035
[TBL] [Abstract][Full Text] [Related]
26. SIRT2 Acts as a Cardioprotective Deacetylase in Pathological Cardiac Hypertrophy.
Tang X; Chen XF; Wang NY; Wang XM; Liang ST; Zheng W; Lu YB; Zhao X; Hao DL; Zhang ZQ; Zou MH; Liu DP; Chen HZ
Circulation; 2017 Nov; 136(21):2051-2067. PubMed ID: 28947430
[TBL] [Abstract][Full Text] [Related]
27. Rosuvastatin reduces platelet activation in heart failure: role of NO bioavailability.
Schäfer A; Fraccarollo D; Eigenthaler M; Tas P; Firnschild A; Frantz S; Ertl G; Bauersachs J
Arterioscler Thromb Vasc Biol; 2005 May; 25(5):1071-7. PubMed ID: 15761193
[TBL] [Abstract][Full Text] [Related]
28. Ginsenoside Re Preserves Cardiac Function and Ameliorates Left Ventricular Remodeling in a Rat Model of Myocardial Infarction.
Yu Y; Sun J; Liu J; Wang P; Wang C
J Cardiovasc Pharmacol; 2020 Jan; 75(1):91-97. PubMed ID: 31599782
[TBL] [Abstract][Full Text] [Related]
29. Rosuvastatin reduces experimental left ventricular infarct size after ischemia-reperfusion injury but not total coronary occlusion.
Weinberg EO; Scherrer-Crosbie M; Picard MH; Nasseri BA; MacGillivray C; Gannon J; Lian Q; Bloch KD; Lee RT
Am J Physiol Heart Circ Physiol; 2005 Apr; 288(4):H1802-9. PubMed ID: 15563531
[TBL] [Abstract][Full Text] [Related]
30. Nicotinamide adenine dinucleotide phosphate oxidase 4 mediates the differential responsiveness of atrial versus ventricular fibroblasts to transforming growth factor-β.
Yeh YH; Kuo CT; Chang GJ; Qi XY; Nattel S; Chen WJ
Circ Arrhythm Electrophysiol; 2013 Aug; 6(4):790-8. PubMed ID: 23884197
[TBL] [Abstract][Full Text] [Related]
31. Soluble guanylyl cyclase activation improves progressive cardiac remodeling and failure after myocardial infarction. Cardioprotection over ACE inhibition.
Fraccarollo D; Galuppo P; Motschenbacher S; Ruetten H; Schäfer A; Bauersachs J
Basic Res Cardiol; 2014 Jul; 109(4):421. PubMed ID: 24907870
[TBL] [Abstract][Full Text] [Related]
32. BMP-7 attenuates left ventricular remodelling under pressure overload and facilitates reverse remodelling and functional recovery.
Merino D; Villar AV; García R; Tramullas M; Ruiz L; Ribas C; Cabezudo S; Nistal JF; Hurlé MA
Cardiovasc Res; 2016 Jun; 110(3):331-45. PubMed ID: 27068510
[TBL] [Abstract][Full Text] [Related]
33. Chronic exposure to environmental contaminant nonylphenol exacerbates adenine-induced chronic renal insufficiency: role of signaling pathways and therapeutic impact of rosuvastatin.
Yen CH; Lin KC; Leu S; Sun CK; Chang LT; Chai HT; Chung SY; Chang HW; Ko SF; Chen YT; Yip HK
Eur J Pharm Sci; 2012 Aug; 46(5):455-67. PubMed ID: 22484332
[TBL] [Abstract][Full Text] [Related]
34. Rosuvastatin increases vascular endothelial PPARgamma expression and corrects blood pressure variability in obese dyslipidaemic mice.
Desjardins F; Sekkali B; Verreth W; Pelat M; De Keyzer D; Mertens A; Smith G; Herregods MC; Holvoet P; Balligand JL
Eur Heart J; 2008 Jan; 29(1):128-37. PubMed ID: 18063594
[TBL] [Abstract][Full Text] [Related]
35. Long-term administration of rosuvastatin prevents contractile and electrical remodelling of diabetic rat heart.
Ozturk N; Yaras N; Ozmen A; Ozdemir S
J Bioenerg Biomembr; 2013 Aug; 45(4):343-52. PubMed ID: 23640692
[TBL] [Abstract][Full Text] [Related]
36. Qiliqiangxin Attenuates Cardiac Remodeling via Inhibition of TGF-β1/Smad3 and NF-κB Signaling Pathways in a Rat Model of Myocardial Infarction.
Han A; Lu Y; Zheng Q; Zhang J; Zhao Y; Zhao M; Cui X
Cell Physiol Biochem; 2018; 45(5):1797-1806. PubMed ID: 29510381
[TBL] [Abstract][Full Text] [Related]
37. Rosuvastatin ameliorates high-fat and high-cholesterol diet-induced nonalcoholic steatohepatitis in rats.
Okada Y; Yamaguchi K; Nakajima T; Nishikawa T; Jo M; Mitsumoto Y; Kimura H; Nishimura T; Tochiki N; Yasui K; Mitsuyoshi H; Minami M; Kagawa K; Okanoue T; Itoh Y
Liver Int; 2013 Feb; 33(2):301-11. PubMed ID: 23295058
[TBL] [Abstract][Full Text] [Related]
38. Effects of rosuvastatin on ADMA, rhokinase, NADPH oxidase, caveolin-1, hsp 90 and NFkB levels in a rat model of myocardial ischaemia-reperfusion.
Burma O; Onat E; Uysal A; Ilhan N; Erol D; Ozcan M; Sahna E
Cardiovasc J Afr; 2014; 25(5):212-6. PubMed ID: 25629537
[TBL] [Abstract][Full Text] [Related]
39. Hepatic and systemic effects of rosuvastatin on an experimental model of bile duct ligation in rats.
Olteanu D; Nagy A; Dudea M; Filip A; Muresan A; Catoi C; Mircea PA; Clichici S
J Physiol Pharmacol; 2012 Oct; 63(5):483-96. PubMed ID: 23211302
[TBL] [Abstract][Full Text] [Related]
40. AMPKα1 deletion in myofibroblasts exacerbates post-myocardial infarction fibrosis by a connexin 43 mechanism.
Dufeys C; Daskalopoulos EP; Castanares-Zapatero D; Conway SJ; Ginion A; Bouzin C; Ambroise J; Bearzatto B; Gala JL; Heymans S; Papageorgiou AP; Vinckier S; Cumps J; Balligand JL; Vanhaverbeke M; Sinnaeve P; Janssens S; Bertrand L; Beauloye C; Horman S
Basic Res Cardiol; 2021 Feb; 116(1):10. PubMed ID: 33564961
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
